Estrogen Modulates Xanthine Dehydrogenase/Xanthine Oxidase Activity by a Receptor-Independent Mechanism

Antioxidants and Redox Signaling

Volumn 5, Issue 6, 2003, Pages 705-711

  Budhiraja, Rohit ^a   Kayyali, Usamah S ^a   Karamsetty, Mallik ^a   Fogel, Michael ^a   Hill, Nicholas S ^a   Chalkley, Roger ^c   Finlay, Geraldine A ^a   Hassoun, Paul M ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ESTRADIOL; ESTRADIOL; ESTROGEN; FULVESTRANT; HORMONE RECEPTOR BLOCKING AGENT; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; HYPOXIA; LUNG ARTERY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; STEREOISOMERISM;

ANIMALIA;

EID: 0345690186     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308603770380007     Document Type: Article

References (49)

1. 2-dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin. J Biol Chem 265: 14170-14175, 1990.
2. Ayres S, Tang M, and Subbiah MT. Estradiol-17beta as an antioxidant: some distinct features when compared with common fat-soluble antioxidants. J Lab Clin Med 128: 367-375, 1996.
3. Beckman JS, Parks DA, Pearson JD, Marshall PA, and Freeman BA. A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radic Biol Med 6: 607-615, 1989.
4. Behl C, Widmann M, Trapp T, and Holsboer E 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216: 473-482, 1995.
5. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, and Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51: 535-541, 1997.
6. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
7. Buko VU, Lukivskaya O, Naruta E, Popov Y, Chirkin A, Chirkina I, Oettel M, Romer W, and Hubler D. Antiatherogenic effects of 17 beta-estradiol and 17 alpha-estradiol and its derivative J811 in cholesterol-fed rabbits with thyroid inhibition. Climacteric 4: 49-57, 2001.
8. Butler R, Morris AD, Belch JJ, Hill A, and Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35: 746-751, 2000.
9. Cai M and Ogawa R. Effects of free radical scavengers, methylprednisolone, and ulinastatin on acute xanthine and xanthine oxidase-induced lung injury in rats. Circ Shock 43: 71-78, 1994.
10. Calderon FH, Bonnefont A, Munoz FJ, Fernandez V, Videla LA, and Inestrosa NC. PC12 and neuro 2a cells have different susceptibilities to acetylcholinesteraseamyloid complexes, amyloid25-35 fragment, glutamate, and hydrogen peroxide. J Neurosci Res 56: 620-631, 1999.
11. Cardillo C, Kilcoyne CM, Cannon RO 3rd, Quyyumi AA, and Panza JA. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 30: 57-63, 1997.
12. Cote CG, Yu FS, Zulueta JJ, Vosatka RJ, and Hassoun PM. Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. Am J Physiol 271: L869-L874, 1996.
13. Farhat MY, Chen MF, Bhatti T, Iqbal A, Cathapermal S, and Ramwell PW. Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats. Br J Pharmacol 110: 719-723, 1993.
14. Garcia-Segura LM, Azcoitia I, and DonCarlos LL. Neuroprotection by estradiol. Prog Neurobiol 63: 29-60, 2001.
15. Green PS and Simpkins JW. Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18: 347-358, 2000.
16. Grosso MA, Brown JM, Viders DE, Mulvin DW, Banerjee A, Velasco SE, Repine JE, and Harken AH. Xanthine oxidase-derived oxygen radicals induce pulmonary edema via direct endothelial cell injury. J Surg Res 46: 355-360, 1989.
17. Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med 33: 774-797, 2002.
18. Hassoun PM, Yu FS, Shedd AL, Zulueta JJ, Thannickal VJ, Lanzillo JJ, and Fanburg BL. Regulation of endothelial cell xanthine dehydrogenase xanthine oxidase gene expression by oxygen tension. Am J Physiol 266: L163-L171, 1994.
19. Hassoun PM, Yu FS, Cote CG, Zulueta JJ, Sawhney R, Skinner KA, Skinner HB, Parks DA, and Lanzillo JJ. Up-regulation of xanthine oxidase by lipopolysaccharide, interleukin-1, and hypoxia. Role in acute lung injury. Am J Respir Crit Care Med 158: 299-305, 1998.
20. Hoshikawa Y, Ono S, Suzuki S, Tanita T, Chida M, Song C, Noda M, Tabata T, Voelkel NF, and Fujimura S. Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. J Appl Physiol 90: 1299-1306, 2001.
21. Kakita T, Suzuki M, Takeuchi H, Unno M, and Matsuno S. Significance of xanthine oxidase in the production of intracellular oxygen radicals in an in-vitro hypoxiareoxygenation model. J Hepatobiliary Pancreat Surg 9: 249-255, 2002.
22. Karas RH, Hodgin JB, Kwoun M, Krege JH, Aronovitz M, Mackey W, Gustafsson JA, Korach KS, Smithies O, and Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. Proc Natl Acad Sci USA 96: 15133-15136, 1999.
23. Karbownik M, Reiter RJ, Burkhardt S, Gitto E, Tan DX, and Lewinski A. Melatonin attenuates estradiol-induced oxidative damage to DNA: relevance for cancer prevention. Exp Biol Med (Maywood) 226: 707-712, 2001.
24. Kayyali US, Donaldson C, Huang H, Abdelnour R, and Hassoun PM. Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia. J Biol Chem 276: 14359-14365, 2001.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
26. Martinez R, Quintana K, Navarro R, Martin C, Hernandez ML, Aurrekoetxea I, Ruiz-Sanz JI, Lacort M, and Ruiz-Larrea MB. Pro-oxidant and antioxidant potential of catecholestrogens against ferrylmyoglobin-induced oxidative stress. Biochim Biophys Acta 1583: 167-175, 2002.
27. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163, 1985.
28. Moosmann B and Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci USA 96: 8867-8872, 1999.
29. Newaz MA, Adeeb NN, Muslim N, Razak TA, and Htut NN. Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive subjects. Clin Exp Hypertens 18: 1035-1050, 1996.
30. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, and Gustafsson JA. Mechanisms of estrogen action. Physiol Rev 81: 1535-1565, 2001.
31. Parker TA, Ivy DD, Galan HL, Grover TR, Kinsella JP. and Abman SH. Estradiol improves pulmonary hemodynamics and vascular remodeling in perinatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 278: L374-L381, 2000.
32. Pesonen EJ, Linder N, Raivio KO, Sarnesto A, Lapatto R, Hockerstedt K, Makisalo H, and Andersson S. Circulating xanthine oxidase and neutrophil activation during human liver transplantation. Gastroenterology 114: 1009-1015, 1998.
33. Poggetti RS, Moore FA, Moore EE, Koeike K, and Banerjee A. Simultaneous liver and lung injury following gut ischemia is mediated by xanthine oxidase. J Trauma 32: 723-727; discussion 727-728, 1992.
34. Quinlan GJ, Lamb NJ, Tilley R, Evans TW, and Gutteridge JM. Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality. Am J Respir Crit Care Med 155: 479-484, 1997.
35. Regan RF and Guo Y. Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures. Brain Res 764: 133-140, 1997.
36. Resta TC, Kanagy NL, and Walker BR. Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression. Am J Physiol Lung Cell Mol Physiol 280: L88-L97, 2001.
37. Rifici VA and Khachadurian AK. The inhibition of low-density lipoprotein oxidation by 17-beta estradiol. Metabolism 41: 1110-1114, 1992.
38. Subbiah MT and Abplanalp W. Evidence of increased formation of products retaining strong antioxidant activity from estradiol-17beta oxidation in the presence of human plasma lipoproteins. J Lab Clin Med 139: 357-363, 2002.
39. Tamir S, Izrael S, and Vaya J. The effect of oxidative stress on ERalpha and ERbeta expression. J Steroid Biochem Mol Biol 81: 327-332, 2002.
40. Tan S, Gelman S, Wheat JK, and Parks DA. Circulating xanthine oxidase in human ischemia reperfusion. South Med J 88: 479-482, 1995.
41. Tate RM, Morris HG, Schroeder WR, and Repine JE. Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs. J Clin Invest 74: 608-613, 1984.
42. Thibodeau PA, Kachadourian R, Lemay R, Bisson M, Day BJ, and Paquette B. In vitro pro- and antioxidant properties of estrogens. J Steroid Biochem Mol Biol 81: 227-236, 2002.
43. Wagner AH, Schroeter MR, and Hecker M. 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 15: 2121-2130, 2001.
44. Wassmann S, Baumer AT, Strehlow K, van Eickels M, Grohe C, Ahlbory K, Rosen R, Bohm M, and Nickenig G. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 103: 435-441, 2001.
45. Weinbroum A, Nielsen VG, Tan S, Gelman S, Matalon S, Skinner KA, Bradley E Jr, and Parks DA. Liver ischemia-reperfusion increases pulmonary permeability in rat: role of circulating xanthine oxidase. Am J Physiol 268: G988-G996, 1995.
46. White RE. Estrogen and vascular function. Vascul Pharmacol 38: 73-80, 2002.
47. Yen CH, Hsieh CC, Chou SY, and Lau YT. 17Beta-estradiol inhibits oxidized low density lipoprotein-induced generation of reactive oxygen species in endothelial cells. Life Sci 70: 403413, 2001.
48. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, and Breitner JC. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288: 2123-2129, 2002.
49. Zulueta JJ, Sawhney R, Yu FS, Cote CC, and Hassoun PM. Intracellular generation of reactive oxygen species in endothelial cells exposed to anoxia-reoxygenation. Am J Physiol 272: L897-L902, 1997.